Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

356
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
356

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correlation of Tumor Absorbed Dose with Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer Treated with <sup>177</sup>Lu-PSMA.

Journal of nuclear medicine technology·2026
Same author

Rapid Predictive Dosimetry Is Now Freely Available.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025
Same author

Direct Correlation of Tumor Absorbed Dose with Overall Survival in Metastatic Castration-Resistant Prostate Cancer Treated with <sup>177</sup>Lu Prostate-Specific Membrane Antigen.

Journal of nuclear medicine technology·2025
Same author

177 Lu-PSMA With Olaparib Radiosensitization Potentiates Response and Toxicity in Extensive Castration-Resistant Metastatic Prostate cancer.

Clinical nuclear medicine·2024
Same author

First-Strike Rapid Predictive Dosimetry and Dose Response for <sup>177</sup>Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer.

Journal of nuclear medicine technology·2024
Same author

Rapid predictive dosimetry for radioembolization.

Asia Oceania journal of nuclear medicine & biology·2024

Related Experiment Video

Updated: Jul 16, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.0K

A simplified general schema for rapid single time-point marrow predictive dosimetry.

Yung Hsiang Kao1

  • 1Department of Nuclear Medicine, The Royal Melbourne Hospital, Victoria, Australia.

Nuclear Medicine Communications
|September 14, 2023
PubMed
Summary

A simplified method for predicting red marrow radiation dose is proposed. This approach uses single-time-point imaging, making dosimetry practical for routine systemic radionuclide therapy.

More Related Videos

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.8K
Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.3K

Related Experiment Videos

Last Updated: Jul 16, 2025

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
09:49

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

10.0K
Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

15.8K
Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.3K

Area of Science:

  • Nuclear Medicine
  • Medical Imaging
  • Radiation Oncology

Background:

  • Red marrow is a critical dose-limiting organ in systemic radionuclide therapy.
  • Current multi-time-point dosimetry is complex and not feasible for routine clinical use.
  • Existing single-time-point methods lack specificity for marrow dosimetry.

Purpose of the Study:

  • To develop a simplified, rapid, and practical method for predictive red marrow dosimetry.
  • To propose a single-time-point imaging approach for systemic radionuclide therapy.
  • To create a generalized schema applicable to various radionuclide therapies.

Main Methods:

  • Direct image quantification of radioconcentration within the marrow.
  • Development of a simplified schema for predictive dosimetry.
  • Validation of the method for systemic radionuclide therapy.

Main Results:

  • A simplified schema for rapid marrow predictive dosimetry was proposed.
  • The method relies on direct image quantification of marrow radioconcentration.
  • The proposed schema is generalizable to most systemic radionuclide therapies.

Conclusions:

  • A practical single-time-point method for red marrow dosimetry in radionuclide therapy is presented.
  • This approach streamlines dosimetric workflows, enhancing clinical applicability.
  • The proposed schema offers a generalized solution for predictive marrow dosimetry.